Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

31,076 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mutant PIK3CA as a negative predictive biomarker for treatment with a highly selective PIM1 inhibitor in human colon cancer.
Park YS, Kim J, Ryu YS, Moon JH, Shin YJ, Kim JH, Hong SW, Jung SA, Lee S, Kim SM, Lee DH, Kim DY, Yun H, You JE, Yoon DI, Kim CH, Koh DI, Jin DH. Park YS, et al. Among authors: kim dy, kim ch, kim sm, kim j, kim jh. Cancer Biol Ther. 2023 Dec 31;24(1):2246208. doi: 10.1080/15384047.2023.2246208. Cancer Biol Ther. 2023. PMID: 37621144 Free PMC article.
Cellular inhibitor of apoptosis protein 1 (cIAP1) stability contributes to YM155 resistance in human gastric cancer cells.
Jung SA, Park YM, Hong SW, Moon JH, Shin JS, Lee HR, Ha SH, Lee DH, Kim JH, Kim SM, Kim JE, Kim KP, Hong YS, Choi EK, Lee JS, Jin DH, Kim T. Jung SA, et al. Among authors: kim kp, kim t, kim sm, kim je, kim jh. J Biol Chem. 2015 Apr 17;290(16):9974-85. doi: 10.1074/jbc.M114.600874. Epub 2015 Jan 29. J Biol Chem. 2015. PMID: 25635055 Free PMC article.
A novel small-molecule IAP antagonist, AZD5582, draws Mcl-1 down-regulation for induction of apoptosis through targeting of cIAP1 and XIAP in human pancreatic cancer.
Moon JH, Shin JS, Hong SW, Jung SA, Hwang IY, Kim JH, Choi EK, Ha SH, Kim JS, Kim KM, Hong DW, Kim D, Kim YS, Kim JE, Kim KP, Hong YS, Choi EK, Lee JS, Hattersley M, Jin DH, Kim TW. Moon JH, et al. Among authors: kim km, kim tw, kim d, kim kp, kim js, kim ys, kim je, kim jh. Oncotarget. 2015 Sep 29;6(29):26895-908. doi: 10.18632/oncotarget.4822. Oncotarget. 2015. PMID: 26314849 Free PMC article.
SAHA, an HDAC inhibitor, overcomes erlotinib resistance in human pancreatic cancer cells by modulating E-cadherin.
Park SJ, Kim SM, Moon JH, Kim JH, Shin JS, Hong SW, Shin YJ, Lee DH, Lee EY, Hwang IY, Kim JE, Kim KP, Hong YS, Lee WK, Choi EK, Lee JS, Jin DH, Kim TW. Park SJ, et al. Among authors: kim tw, kim kp, kim sm, kim je, kim jh. Tumour Biol. 2016 Apr;37(4):4323-30. doi: 10.1007/s13277-015-4216-2. Epub 2015 Oct 22. Tumour Biol. 2016. PMID: 26493999
L-Ascorbic acid can abrogate SVCT-2-dependent cetuximab resistance mediated by mutant KRAS in human colon cancer cells.
Jung SA, Lee DH, Moon JH, Hong SW, Shin JS, Hwang IY, Shin YJ, Kim JH, Gong EY, Kim SM, Lee EY, Lee S, Kim JE, Kim KP, Hong YS, Lee JS, Jin DH, Kim T, Lee WJ. Jung SA, et al. Among authors: kim kp, kim t, kim sm, kim je, kim jh. Free Radic Biol Med. 2016 Jun;95:200-8. doi: 10.1016/j.freeradbiomed.2016.03.009. Epub 2016 Mar 22. Free Radic Biol Med. 2016. PMID: 27012422
SH003 selectively induces p73‑dependent apoptosis in triple‑negative breast cancer cells.
Choi EK, Kim SM, Hong SW, Moon JH, Shin JS, Kim JH, Hwang IY, Jung SA, Lee DH, Lee EY, Lee S, Kim H, Kim D, Kim YS, Choi YK, Kim HI, Choi HS, Cho SG, Kim JE, Kim KP, Hong YS, Lee WK, Lee JS, Kim TW, Ko SG, Jin DH. Choi EK, et al. Among authors: kim h, kim hi, kim tw, kim d, kim kp, kim sm, kim ys, kim je, kim jh. Mol Med Rep. 2016 Oct;14(4):3955-60. doi: 10.3892/mmr.2016.5722. Epub 2016 Sep 6. Mol Med Rep. 2016. PMID: 27599791
31,076 results
You have reached the last available page of results. Please see the User Guide for more information.